WHO ICTRP trial
A randomiszed, mono-center, placebo-controlled, double-blind, comparative study…
EUCTR2011-005336-25-DE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2011-005336-25-DE |
|---|---|
| Public title | A randomiszed, mono-center, placebo-controlled, double-blind, comparative study to evaluate the efficacy and safety of Dynexan® Mundgel in minors with acute painful sites of the mouth |
| Scientific title | A randomiszed, mono-center, placebo-controlled, double-blind, comparative study to evaluate the efficacy and safety of Dynexan® Mundgel in minors with acute painful sites of the mouth. - Dynexan® in children with acute painful sites of the mouth |
| Primary sponsor | Chemische Fabrik Kreussler & Co. GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Painful sites in the mouth;Therapeutic area: Diseases [C] - Mouth and tooth diseases [C07] |
| Interventions | Trade Name: Dynexan Mundgel Product Name: Dynexan Mundgel Pharmaceutical Form: Gel INN or Proposed INN: LIDOCAINE CAS Number: 137-58-6 Concentration unit: mg/g milligram(s)/gram Concentration type: equal Concentration number: 20… |
| Registration date | Jan 31, 2012 |
| Secondary IDs | DMKS-2011 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: